0001140361-17-036963.txt : 20170929
0001140361-17-036963.hdr.sgml : 20170929
20170929163657
ACCESSION NUMBER: 0001140361-17-036963
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170927
FILED AS OF DATE: 20170929
DATE AS OF CHANGE: 20170929
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Abdun-Nabi Daniel
CENTRAL INDEX KEY: 0001380187
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 171111905
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DRIVE
STREET 2: SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
doc1.xml
FORM 4
X0306
4
2017-09-27
0
0001367644
Emergent BioSolutions Inc.
EBS
0001380187
Abdun-Nabi Daniel
400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG
MD
20879
1
1
0
0
President & CEO
Common Stock
2017-09-27
4
M
0
15000
22.03
A
219134
D
Common Stock
2017-09-27
4
S
0
15000
39.918
D
204134
D
Common Stock
1000
I
By Son
Stock Option (Right to Buy)
22.03
2017-09-27
4
M
0
15000
0
D
2018-03-14
Common Stock
15000
11508
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.85 to $39.98, inclusive.
The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Consists of an option granted under the company's stock incentive plan as amended and restated.
The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.
/s/ Eric Burt, Attorney-in-fact
2017-09-29